An 18-year old college freshman presents to his university clinic because he has not been feeling well for the past two weeks. He has had a persistent headache, occasional cough, and chills without rigors. The patient’s vital signs are normal and physical exam is unremarkable. His radiograph shows patchy interstitial lung infiltrates and he is diagnosed with atypical pneumonia. The patient is prescribed azithromycin and takes his medication as instructed. Despite adherence to his drug regimen, he returns to the clinic one week later because his symptoms have not improved. The organism responsible for this infection is likely resistant to azithromycin through which mechanism?

Methylation of ribosomal binding site

Decreased binding to RNA polymerase

A 33-year-old woman presents to her local clinic in rural eastern India complaining of neck pain and fever. She reports a 4 day history of severe neck pain, neck stiffness, mild diarrhea, and fever. She has not taken her temperature. She works as a laborer and frequently carries heavy weights on her back. She is prescribed a medication and told to come back if her symptoms do not improve. Her symptoms resolve after a couple days. Six months later, she gives birth to a newborn male at 34 weeks gestation. His temperature is 97.8°F (36.6°C), blood pressure is 90/55 mmHg, pulse is 110/min, and respirations are 24/min. On examination, the baby is irritable with a weak cry. Ashen gray cyanosis is noted diffusely. What is the mechanism of action of the drug responsible for this child's presentation?

50S ribosomal subunit inhibitor

DNA-dependent RNA polymerase inhibitor

Dihydropteroate synthase inhibitor

30S ribosomal subunit inhibitor

A 61-year-old woman who recently emigrated from India comes to the physician because of a 2-month history of fever, fatigue, night sweats, and a productive cough. She has had a 5-kg (11-lb) weight loss during this period. She has a history of type 2 diabetes mellitus and poorly controlled asthma. She has had multiple asthma exacerbations in the past year that were treated with glucocorticoids. An x-ray of the chest shows a cavitary lesion of the posterior apical segment of the left upper lobe with consolidation of the surrounding parenchyma. The pathogen identified on sputum culture is found to be resistant to multiple drugs, including streptomycin. Which of the following mechanisms is most likely involved in bacterial resistance to this drug?

Alteration in 30S ribosomal subunit

Alteration in the sequence of gyrA genes

Upregulation of arabinosyl transferase production

Upregulation of mycolic acid synthesis

Inhibition of bacterial synthesis of RNA

A 22-year-old woman presents to the emergency department because of agitation and sweating. History shows she is currently being treated for depression with citalopram. She also takes tramadol for back pain. Her temperature is 38.6°C (101.5°F), the pulse is 108/min, the respirations are 18/min, and the blood pressure is 165/110 mm Hg. Physical examination shows hyperreflexia and mild tremors in all 4 extremities. Which of the following should be used in the next step of management for this patient?

Discontinue tramadol and citalopram

A 58-year-old female presents to her primary care physician with a 1-month history of facial and chest flushing, as well as intermittent diarrhea and occasional difficulty breathing. On physical exam, a new-onset systolic ejection murmur is auscultated and is loudest at the left second intercostal space. Subsequent echocardiography reveals leaflet thickening secondary to fibrous plaque deposition on both the pulmonic and tricuspid valves. Which of the following laboratory abnormalities would most likely be found in this patient?

Elevated urinary 5-hydroxyindoleacetic acid

Elevated urinary vanillylmandelic acid

Oxazolidinones and streptogramins for USMLE Step 1: High-Yield Pharmacology Lessons

Mechanism of Action - Protein Factory Sabotage

Both classes target the bacterial 50S ribosomal subunit, but at different stages of protein synthesis.

Oxazolidinones (e.g., Linezolid)
- Bind to a unique site on the 23S rRNA of the 50S subunit.
- Prevent the assembly of the 70S initiation complex, a very early step.
- This blocks the binding of the initiator tRNA (fMet-tRNA).
- Primarily bacteriostatic.
Streptogramins (Quinupristin-Dalfopristin)
- Synergistic pair that binds the 50S subunit.
- Dalfopristin (A): Induces a conformational change.
- Quinupristin (B): Binds the altered site, blocking peptide elongation and causing premature release of incomplete peptides.
- Bactericidal in combination for most organisms.

⭐ High-Yield: Because Linezolid inhibits protein synthesis at the initiation phase, a mechanism distinct from other 50S inhibitors, it typically lacks cross-resistance with them.

Oxazolidinones (Linezolid) - The 'Zolid' MRSA Fighter

Mechanism: Binds to the 50S ribosomal subunit at the 23S rRNA site, uniquely preventing the formation of the 70S initiation complex. Generally bacteriostatic.
Spectrum & Use:
- Gram-Positives: Methicillin-resistant S. aureus (MRSA) and Vancomycin-resistant Enterococci (VRE - faecium & faecalis).
- Clinical: Reserved for multi-drug resistant infections like hospital-acquired pneumonia (HAP/VAP) and complicated skin/soft tissue infections (cSSTI). High oral bioavailability (~100%) facilitates easy IV-to-PO transition.
Adverse Effects & Warnings:
- Bone Marrow Suppression: Reversible, duration-dependent thrombocytopenia is most common. Monitor CBC.
- Neuropathy: Peripheral and optic neuropathy with use >28 days.
- Lactic Acidosis.

⭐ Serotonin Syndrome: Linezolid is a weak, reversible monoamine oxidase inhibitor (MAOI). Avoid co-administration with serotonergic agents (SSRIs, SNRIs, TCAs) to prevent this life-threatening toxicity. 📌 Mnemonic: Get in LINE for the ZOLID stuff to fight MRSA/VRE, but watch your blood LINEs (CBC) and your happy LINE (serotonin syndrome).

Streptogramins - The Synergistic Duo

Composition: A synergistic IV combination of Quinupristin (streptogramin B) and Dalfopristin (streptogramin A), typically in a 30:70 ratio.
Mechanism of Action:
- Both bind the 50S ribosomal subunit at a site overlapping with macrolides, blocking protein synthesis.
- Dalfopristin changes the ribosome's shape, which ↑ quinupristin's binding affinity.
- The combination is bactericidal; components are bacteriostatic alone.
Clinical Spectrum:
- Reserved for serious, multi-drug-resistant (MDR) gram-positive infections.
- Key uses: Vancomycin-Resistant Enterococcus faecium (VRE) and MRSA.
Adverse Effects & Interactions:
- Infusion-related reactions: severe phlebitis and pain (often requires central line).
- Arthralgia-myalgia syndrome is common.
- Potent CYP3A4 inhibitor, leading to numerous drug interactions (e.g., statins, warfarin).

⭐ Exam Favorite: Streptogramins are a key therapy for VRE, but only for Enterococcus faecium. They are intrinsically ineffective against E. faecalis, which possesses an efflux pump to remove the drug.

High‑Yield Points - ⚡ Biggest Takeaways

Linezolid and Streptogramins both inhibit protein synthesis by binding the 50S ribosomal subunit.

Linezolid is a key treatment for MRSA and VRE; major toxicities include thrombocytopenia, optic neuritis, and serotonin syndrome.

Quinupristin-dalfopristin is reserved for complicated VRE infections (not E. faecalis).

Watch for arthralgia-myalgia syndrome and significant CYP450 inhibition with streptogramins.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play